Katelyn T. Byrne
Oregon Health & Science University(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Pancreatic and Hepatic Oncology Research, CAR-T cell therapy research, Cancer Cells and Metastasis, Immunotherapy and Immune Responses
Most-Cited Works
- → Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications(2020)1,644 cited
- → Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy(2018)732 cited
- → Immunotherapy and Prevention of Pancreatic Cancer(2018)464 cited
- → Induction of T-cell Immunity Overcomes Complete Resistance to PD-1 and CTLA-4 Blockade and Improves Survival in Pancreatic Carcinoma(2015)460 cited
- → Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial(2022)325 cited
- → CD40 agonistic monoclonal antibody APX005M (sotigalimab) and chemotherapy, with or without nivolumab, for the treatment of metastatic pancreatic adenocarcinoma: an open-label, multicentre, phase 1b study(2020)289 cited
- → CD40 Stimulation Obviates Innate Sensors and Drives T Cell Immunity in Cancer(2016)281 cited
- → Resident memory T cells in the skin mediate durable immunity to melanoma(2017)271 cited
- → Deep immune profiling of MIS-C demonstrates marked but transient immune activation compared with adult and pediatric COVID-19(2021)202 cited
- → Lack of immunoediting in murine pancreatic cancer reversed with neoantigen(2016)179 cited